首页 > 最新文献

The Journal of Association of Chest Physicians最新文献

英文 中文
Our experience of thoracic surgery during COVID19 pandemic 我们在covid - 19大流行期间的胸外科经验
Pub Date : 2020-07-01 DOI: 10.4103/jacp.jacp_38_20
A. Chakrabarti, Manujesh Bandyopadhyay
COVID19 pandemic has badly affected thoracic surgical services. In this difficult time Thoracic surgeons all over the world are boldly managing thoracic malignancies and life-threatening problems of benign thoracic diseases. Infection control, safety of patients & healthcare personnel remains the cornerstone. In this article we present our experience of Thoracic surgery during this pandemic. Our results & experience are similar to the guidelines & survey reports published by thoracic surgeons till date.
新冠肺炎疫情严重影响了胸外科服务。在这个艰难的时刻,全世界的胸科医生都在大胆地治疗胸部恶性肿瘤和危及生命的良性胸科疾病。感染控制、患者和医护人员的安全仍然是基石。在这篇文章中,我们介绍了我们在这场疫情期间进行胸科手术的经验。我们的结果和经验与迄今为止胸外科医生发布的指南和调查报告相似。
{"title":"Our experience of thoracic surgery during COVID19 pandemic","authors":"A. Chakrabarti, Manujesh Bandyopadhyay","doi":"10.4103/jacp.jacp_38_20","DOIUrl":"https://doi.org/10.4103/jacp.jacp_38_20","url":null,"abstract":"COVID19 pandemic has badly affected thoracic surgical services. In this difficult time Thoracic surgeons all over the world are boldly managing thoracic malignancies and life-threatening problems of benign thoracic diseases. Infection control, safety of patients & healthcare personnel remains the cornerstone. In this article we present our experience of Thoracic surgery during this pandemic. Our results & experience are similar to the guidelines & survey reports published by thoracic surgeons till date.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43980112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cross-sectional study on tobacco use prevalence and reasons for its use among male youth in a resettlement colony of Delhi 德里安置区男性青年吸烟流行率及其使用原因的横断面研究
Pub Date : 2020-07-01 DOI: 10.4103/jacp.jacp_32_19
V. Yadav, D. Dabar
Introduction: It is estimated that 5,500 adolescents started using tobacco every day in India. The prevention of tobacco use in young Indians appears to be one of the largest opportunities for controlling this ever-growing epidemic. In India, like in other developing countries, the most susceptible time for initiation of tobacco is during youth, that is in the age group of 15–24 years. Material and Methods: This cross-sectional study was conducted in Kalyanpuri, a resettlement colony in New Delhi, India. The study included males aged 15–24 years residing in the study area at the time of survey. A semi-structured interview schedule was designed and translated into Hindi to elicit information on tobacco use. Results: Prevalence of tobacco use (ever user) was found to be 31.3%. Among ever users, 225 (27.7%) were current users and 9 (3.6%) were past users. Peer pressure (140, 62.2%) was found to be most common reason for initiation, whereas habit (143, 63.5%) of having tobacco was most common reason for continuation of tobacco use.
引言:据估计,印度每天有5500名青少年开始吸烟。防止印度年轻人吸烟似乎是控制这种日益增长的流行病的最大机会之一。在印度,与其他发展中国家一样,最容易开始吸烟的时间是青年时期,即15-24岁的年龄组。材料和方法:这项横断面研究在印度新德里的Kalyanpuri安置地进行。该研究包括调查时居住在研究区域的15-24岁男性。设计了一份半结构化的访谈时间表,并将其翻译成印地语,以获取有关烟草使用的信息。结果:吸烟的患病率(曾经使用过)为31.3%。在曾经使用过烟草的人中,225人(27.7%)是现在的使用者,9人(3.6%)是过去的使用者。同伴压力(14062.2%)是开始吸烟的最常见原因,而吸烟习惯(14363.5%)是继续吸烟的最常用原因。
{"title":"A cross-sectional study on tobacco use prevalence and reasons for its use among male youth in a resettlement colony of Delhi","authors":"V. Yadav, D. Dabar","doi":"10.4103/jacp.jacp_32_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_32_19","url":null,"abstract":"Introduction: It is estimated that 5,500 adolescents started using tobacco every day in India. The prevention of tobacco use in young Indians appears to be one of the largest opportunities for controlling this ever-growing epidemic. In India, like in other developing countries, the most susceptible time for initiation of tobacco is during youth, that is in the age group of 15–24 years. Material and Methods: This cross-sectional study was conducted in Kalyanpuri, a resettlement colony in New Delhi, India. The study included males aged 15–24 years residing in the study area at the time of survey. A semi-structured interview schedule was designed and translated into Hindi to elicit information on tobacco use. Results: Prevalence of tobacco use (ever user) was found to be 31.3%. Among ever users, 225 (27.7%) were current users and 9 (3.6%) were past users. Peer pressure (140, 62.2%) was found to be most common reason for initiation, whereas habit (143, 63.5%) of having tobacco was most common reason for continuation of tobacco use.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47461625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A case of chronic cavitory pulmonary aspergillosis, a rare entity 一例罕见的慢性空腔性肺曲霉菌病
Pub Date : 2020-07-01 DOI: 10.4103/jacp.jacp_2_20
S. Das, Soumyadeep Ghosh, Gopal Sasmal
Aspergillus species cause a wide spectrum of pulmonary disease including allergic, saprophytic, semi-invasive and invasive aspergillosis. Host immune system is the major determinant of the pattern of illness in human beings. Several chronic forms of Aspergillus infections have been described which include chronic cavitary pulmonary aspergillosis (CCPA), chronic fibrotic pulmonary aspergillosis (CFPA) and chronic necrotizing pulmonary aspergillosis (CNPA). Chronic cavitary pulmonary aspergillosis usually runs a progressive course, affects apparently immunocompetent individuals with a pre-existing lung disease. Diagnosis depends on presence of constitutional and pulmonary symptoms, suggestive radiological changes and microbiological or serological evidence of Aspergillus infection. We hereby present a case of 28 years immunocompetent male who had prior history of pulmonary tuberculosis and was subsequently diagnosed as chronic cavitary pulmonary aspergillosis.
曲霉属引起广泛的肺部疾病,包括过敏性、腐生性、半侵袭性和侵袭性曲霉菌病。宿主免疫系统是人类疾病模式的主要决定因素。曲霉菌感染的几种慢性形式已被描述,包括慢性空洞性肺曲霉菌病(CCPA)、慢性纤维化肺曲霉血症(CFPA)和慢性坏死性肺曲霉病(CNPA)。慢性空洞性肺曲霉菌病通常是一个渐进的过程,影响明显具有免疫功能的先前存在肺部疾病的个体。诊断取决于是否存在体质和肺部症状、提示性放射学变化以及曲霉菌感染的微生物学或血清学证据。我们在此报告一例28岁的免疫功能正常男性,其既往有肺结核病史,随后被诊断为慢性空洞性肺曲霉菌病。
{"title":"A case of chronic cavitory pulmonary aspergillosis, a rare entity","authors":"S. Das, Soumyadeep Ghosh, Gopal Sasmal","doi":"10.4103/jacp.jacp_2_20","DOIUrl":"https://doi.org/10.4103/jacp.jacp_2_20","url":null,"abstract":"Aspergillus species cause a wide spectrum of pulmonary disease including allergic, saprophytic, semi-invasive and invasive aspergillosis. Host immune system is the major determinant of the pattern of illness in human beings. Several chronic forms of Aspergillus infections have been described which include chronic cavitary pulmonary aspergillosis (CCPA), chronic fibrotic pulmonary aspergillosis (CFPA) and chronic necrotizing pulmonary aspergillosis (CNPA). Chronic cavitary pulmonary aspergillosis usually runs a progressive course, affects apparently immunocompetent individuals with a pre-existing lung disease. Diagnosis depends on presence of constitutional and pulmonary symptoms, suggestive radiological changes and microbiological or serological evidence of Aspergillus infection. We hereby present a case of 28 years immunocompetent male who had prior history of pulmonary tuberculosis and was subsequently diagnosed as chronic cavitary pulmonary aspergillosis.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42119127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echocardiographic evaluation of stable chronic obstructive pulmonary disease (COPD) patients 稳定期慢性阻塞性肺病(COPD)患者的超声心动图评价
Pub Date : 2020-07-01 DOI: 10.4103/jacp.jacp_40_19
H. Kumar, A. Verma, A. Pandey, Utkarsh Srivastava, M. Pandey, Rishabh Chaudhary, S. Kant
Context: Chronic obstructive pulmonary disease (COPD) is the second leading cause of mortality in India, cardiovascular disease (CVD) comorbidity further increases morbidity and mortality of COPD. Early detection of CVD by echocardiography in COPD helps to reduce mortality and morbidity. Objective: We aimed to assess the echocardiographic findings in stable COPD patients. Materials and Methods: Patients with stable COPD, confirmed by spirometry, were recruited from the two tertiary care centre of India between August 2017 and August 2019. After thorough clinical examinations, patients have undergone echocardiography for CVD evaluation. Results: A total of 110 COPD patients were recruited, 91 male and 19 female. On echocardiographic evaluation, pulmonary arterial hypertension (PAH) was seen in 45.5% of COPD with mild, moderate, severe 14.5%, 11% and 20% respectively. Cor-pulmonale was seen in 9.1%. Left ventricular hypertrophy (LVH), left ventricular diastolic dysfunction (LVDD) and left ventricular systolic dysfunction (LVSD) was seen in 11%, 39.1% and 13.6% of COPD respectively. CVD involvement was more common in very severe COPD (40.1%). Conclusion: In this study, 78.2% of COPD have at least one form of CVD as co-morbidity. A simple, cheaper, non-invasive, widely an available investigation like echocardiography is useful to detect CVD at an early stage.
背景:慢性阻塞性肺病(COPD)是印度第二大死亡原因,心血管疾病(CVD)合并症进一步增加了COPD的发病率和死亡率。超声心动图在COPD中早期发现CVD有助于降低死亡率和发病率。目的:我们旨在评估稳定期COPD患者的超声心动图表现。材料和方法:2017年8月至2019年8月,从印度两个三级护理中心招募经肺活量测定证实的稳定期COPD患者。在彻底的临床检查后,患者接受了超声心动图评估CVD。结果:共招募了110名COPD患者,其中男性91名,女性19名。在超声心动图评估中,45.5%的COPD患者出现肺动脉高压(PAH),轻度、中度、重度分别为14.5%、11%和20%。肺心病占9.1%,COPD患者左心室肥厚(LVH)、左心室舒张功能障碍(LVDD)和左心室收缩功能障碍(LVSD)分别占11%、39.1%和13.6%。CVD在非常严重的COPD中更常见(40.1%)。结论:在本研究中,78.2%的COPD至少有一种形式的CVD作为合并发病。一种简单、廉价、无创、广泛可用的研究,如超声心动图,可用于早期检测CVD。
{"title":"Echocardiographic evaluation of stable chronic obstructive pulmonary disease (COPD) patients","authors":"H. Kumar, A. Verma, A. Pandey, Utkarsh Srivastava, M. Pandey, Rishabh Chaudhary, S. Kant","doi":"10.4103/jacp.jacp_40_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_40_19","url":null,"abstract":"Context: Chronic obstructive pulmonary disease (COPD) is the second leading cause of mortality in India, cardiovascular disease (CVD) comorbidity further increases morbidity and mortality of COPD. Early detection of CVD by echocardiography in COPD helps to reduce mortality and morbidity. Objective: We aimed to assess the echocardiographic findings in stable COPD patients. Materials and Methods: Patients with stable COPD, confirmed by spirometry, were recruited from the two tertiary care centre of India between August 2017 and August 2019. After thorough clinical examinations, patients have undergone echocardiography for CVD evaluation. Results: A total of 110 COPD patients were recruited, 91 male and 19 female. On echocardiographic evaluation, pulmonary arterial hypertension (PAH) was seen in 45.5% of COPD with mild, moderate, severe 14.5%, 11% and 20% respectively. Cor-pulmonale was seen in 9.1%. Left ventricular hypertrophy (LVH), left ventricular diastolic dysfunction (LVDD) and left ventricular systolic dysfunction (LVSD) was seen in 11%, 39.1% and 13.6% of COPD respectively. CVD involvement was more common in very severe COPD (40.1%). Conclusion: In this study, 78.2% of COPD have at least one form of CVD as co-morbidity. A simple, cheaper, non-invasive, widely an available investigation like echocardiography is useful to detect CVD at an early stage.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44601492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Group III Pulmonary Hypertension: relative frequency of different etiologies in a referral pulmonary OPD 第III组肺动脉高压:转诊肺动脉OPD中不同病因的相对频率
Pub Date : 2020-07-01 DOI: 10.4103/jacp.jacp_3_20
P. Bhattacharyya, S. Sengupta, D. Saha, Mintu Paul, Priyanka Choudhury, S. Dasgupta
Background: The prevalence of pulmonary hypertension (PH) in India remains unknown. The literature is scanty from the country regarding different types of PH. The etiological distribution of Group III PH in a pulmonologist’s practice, therefore, will be worthwhile to note. Method: We included patients with pulmonary hypertension following convenience sampling from those been diagnosed with PH in our pulmonary OPD services on the basis of a novel clinico-radio-echocardiographic criteria. They were then evaluated for the apparent and predominant underlying etiology. Patients with clear and defined diagnosis of COPD, asthma, DPLD, OSA and CTEPH were charted along with those having no obvious etiology but a history of treatment of tuberculosis in the past, along with a group marked as the “others” that consisted of a number of known (sarcoidosis, rheumatic heart disease, etc.) and some incompletely evaluated patients. Results: A total of 356 patients were recruited. The relative frequencies have been accounted to 35.81%, 20.66% and 13.77% for COPD, DPLD and asthma respectively. The patients with a history of TB without any other forthcoming etiology formed 12.67% of the group. The patients with OSA and CTEPH accounted for 2.75% of the group and the “Others” group occupied the rest 14.32%. Conclusion: Group III PH is found not infrequent in pulmonary practice and COPD tops the etiological list.
背景:印度肺动脉高压(PH)的患病率尚不清楚。国内关于不同类型PH的文献很少。因此,肺科医生实践中第III组PH的病因分布值得注意。方法:我们根据一项新的临床无线电超声心动图标准,从我们的肺部门诊服务中诊断为肺动脉高压的患者中方便地抽取样本,纳入肺动脉高压患者。然后对其明显和主要的潜在病因进行评估。明确诊断为COPD、哮喘、DPLD、OSA和CTEPH的患者,以及那些没有明显病因但过去有结核病治疗史的患者,还有一组被标记为“其他”的患者,包括一些已知的患者(结节病、风湿性心脏病等)和一些未完全评估的患者。结果:共招募356名患者。COPD、DPLD和哮喘的相对频率分别为35.81%、20.66%和13.77%。有结核病病史但没有任何其他病因的患者占该组的12.67%。OSA和CTEPH患者占该组的2.75%,“其他”组占其余14.32%。
{"title":"Group III Pulmonary Hypertension: relative frequency of different etiologies in a referral pulmonary OPD","authors":"P. Bhattacharyya, S. Sengupta, D. Saha, Mintu Paul, Priyanka Choudhury, S. Dasgupta","doi":"10.4103/jacp.jacp_3_20","DOIUrl":"https://doi.org/10.4103/jacp.jacp_3_20","url":null,"abstract":"Background: The prevalence of pulmonary hypertension (PH) in India remains unknown. The literature is scanty from the country regarding different types of PH. The etiological distribution of Group III PH in a pulmonologist’s practice, therefore, will be worthwhile to note. Method: We included patients with pulmonary hypertension following convenience sampling from those been diagnosed with PH in our pulmonary OPD services on the basis of a novel clinico-radio-echocardiographic criteria. They were then evaluated for the apparent and predominant underlying etiology. Patients with clear and defined diagnosis of COPD, asthma, DPLD, OSA and CTEPH were charted along with those having no obvious etiology but a history of treatment of tuberculosis in the past, along with a group marked as the “others” that consisted of a number of known (sarcoidosis, rheumatic heart disease, etc.) and some incompletely evaluated patients. Results: A total of 356 patients were recruited. The relative frequencies have been accounted to 35.81%, 20.66% and 13.77% for COPD, DPLD and asthma respectively. The patients with a history of TB without any other forthcoming etiology formed 12.67% of the group. The patients with OSA and CTEPH accounted for 2.75% of the group and the “Others” group occupied the rest 14.32%. Conclusion: Group III PH is found not infrequent in pulmonary practice and COPD tops the etiological list.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47548212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrosive esophageal injury caused by impacted button battery 纽扣电池撞击造成的腐蚀性食管损伤
Pub Date : 2020-07-01 DOI: 10.4103/jacp.jacp_41_19
Charulatha Ravindran, S. R, G. Jayaraman
{"title":"Corrosive esophageal injury caused by impacted button battery","authors":"Charulatha Ravindran, S. R, G. Jayaraman","doi":"10.4103/jacp.jacp_41_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_41_19","url":null,"abstract":"","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42640428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of obstructive sleep apnea and sleep parameters on level of asthma control 阻塞性睡眠呼吸暂停及睡眠参数对哮喘控制水平的影响
Pub Date : 2020-01-01 DOI: 10.4103/jacp.jacp_8_19
R. Dixit, Satyadeep Verma, M. Goyal
Background and Objective: Several studies support high prevalence of obstructive sleep apnea (OSA) symptoms in patients with asthma. Our objective was to evaluate the relationship between OSA severity and level of asthma control if any and analyze sleep parameters in patients having different levels of asthma control. Methods: A cross-sectional study among asthma patients having symptoms of sleep-related breathing disorders. Eligible patients were assessed clinically and with sleep questionnaire including asthma control followed by level 1 Polysomnography. Results: Among 53 patients of asthma (mean age 48.16 years), OSA was present in 84.21% of uncontrolled asthma, 35% in partially controlled asthma, and 7.14% in well-controlled asthma. Uncontrolled asthma patients were associated with higher apnea/hypopnea index (AHI) (30.8±17.6 vs. 3.7±1.2; p-value < 0.0001), more time spent in non rapid eye movement (NREM) 1 stage (18.5±11.9% vs. 13.0±11.2% of total sleep time), higher nocturnal desaturation episodes (152.5±13 vs. 22.1±16.7; p-value < 0.001), and severe OSA in supine position (AHI 33.1±17.7 vs. 9.2±9.7; p-value < 0.001) compared with well-controlled asthma. Conclusion: There seems a strong relationship between desaturation events and higher AHI with poor level of asthma control, especially during supine position. OSA must be suspected in patients with uncontrolled asthma. An early detection and treatment of OSA may improve the level of asthma control as well as quality of life in such patients.
背景和目的:几项研究支持哮喘患者阻塞性睡眠呼吸暂停(OSA)症状的高患病率。我们的目的是评估OSA严重程度与哮喘控制水平之间的关系(如果有的话),并分析不同哮喘控制水平患者的睡眠参数。方法:对有睡眠相关呼吸障碍症状的哮喘患者进行横断面研究。对符合条件的患者进行临床评估,并使用睡眠问卷,包括哮喘控制,然后进行1级多导睡眠图检查。结果:在53名哮喘患者(平均年龄48.16岁)中,84.21%的哮喘未得到控制,35%的哮喘部分得到控制,7.14%的哮喘完全得到控制。未受控制的哮喘患者与较高的呼吸暂停/低通气指数(AHI)(30.8±17.6 vs.3.7±1.2;p值<0.001)、更多的非快速眼动(NREM)1期时间(18.5±11.9%vs.13.0±11.2%的总睡眠时间)、较高的夜间去饱和发作(152.5±13 vs.22.1±16.7;p值<0.001)有关,与控制良好的哮喘相比,仰卧位严重OSA(AHI 33.1±17.7vs.9.2±9.7;p值<0.001)。结论:去饱和事件和较高的AHI与哮喘控制水平差之间似乎有着密切的关系,尤其是在仰卧位。哮喘失控的患者必须怀疑OSA。OSA的早期检测和治疗可以提高此类患者的哮喘控制水平和生活质量。
{"title":"Impact of obstructive sleep apnea and sleep parameters on level of asthma control","authors":"R. Dixit, Satyadeep Verma, M. Goyal","doi":"10.4103/jacp.jacp_8_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_8_19","url":null,"abstract":"Background and Objective: Several studies support high prevalence of obstructive sleep apnea (OSA) symptoms in patients with asthma. Our objective was to evaluate the relationship between OSA severity and level of asthma control if any and analyze sleep parameters in patients having different levels of asthma control. Methods: A cross-sectional study among asthma patients having symptoms of sleep-related breathing disorders. Eligible patients were assessed clinically and with sleep questionnaire including asthma control followed by level 1 Polysomnography. Results: Among 53 patients of asthma (mean age 48.16 years), OSA was present in 84.21% of uncontrolled asthma, 35% in partially controlled asthma, and 7.14% in well-controlled asthma. Uncontrolled asthma patients were associated with higher apnea/hypopnea index (AHI) (30.8±17.6 vs. 3.7±1.2; p-value < 0.0001), more time spent in non rapid eye movement (NREM) 1 stage (18.5±11.9% vs. 13.0±11.2% of total sleep time), higher nocturnal desaturation episodes (152.5±13 vs. 22.1±16.7; p-value < 0.001), and severe OSA in supine position (AHI 33.1±17.7 vs. 9.2±9.7; p-value < 0.001) compared with well-controlled asthma. Conclusion: There seems a strong relationship between desaturation events and higher AHI with poor level of asthma control, especially during supine position. OSA must be suspected in patients with uncontrolled asthma. An early detection and treatment of OSA may improve the level of asthma control as well as quality of life in such patients.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48832112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erasmus Syndrome: Co-existence of silicosis and progressive systemic sclerosis in a 55 year old male 伊拉斯谟综合征:55岁男性并发矽肺和进行性系统性硬化
Pub Date : 2020-01-01 DOI: 10.4103/jacp.jacp_9_19
Jitendra Jalutharia, R. Dixit
The Erasmus syndrome describes the association of generalised progressive scleroderma following exposure to silica with or without silicosis. We report a case of Erasmus Syndrome in a 55-year old labourer presenting with shortness of breath, arthralgia, Raynaud’s phenomenon, skin tightening and microstomia along with pulmonary arterial hypertension. Among investigations, serological markers were strongly positive, high-resolution computed tomography chest showed evidence of interstitial lung disease (ILD) with mediastinal lymphadenopathy and histopathology of skin biopsy were suggestive of systemic sclerosis. Correlating the occupational history, clinical features, haematological investigations and histological findings, a diagnosis of Erasmus syndrome was safely made.
伊拉斯谟综合征描述了暴露于二氧化硅后伴有或不伴有矽肺的全身性进行性硬皮病的关联。我们报告一位55岁劳工的伊拉斯谟症候群,表现为呼吸短促、关节痛、雷诺氏现象、皮肤紧绷及小口畸形并肺动脉高压。在调查中,血清学指标呈强烈阳性,高分辨率胸部计算机断层扫描显示间质性肺疾病(ILD)伴纵隔淋巴结病,皮肤活检组织病理学提示系统性硬化症。结合职业史、临床特征、血液学调查和组织学发现,诊断为伊拉斯谟综合征是安全的。
{"title":"Erasmus Syndrome: Co-existence of silicosis and progressive systemic sclerosis in a 55 year old male","authors":"Jitendra Jalutharia, R. Dixit","doi":"10.4103/jacp.jacp_9_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_9_19","url":null,"abstract":"The Erasmus syndrome describes the association of generalised progressive scleroderma following exposure to silica with or without silicosis. We report a case of Erasmus Syndrome in a 55-year old labourer presenting with shortness of breath, arthralgia, Raynaud’s phenomenon, skin tightening and microstomia along with pulmonary arterial hypertension. Among investigations, serological markers were strongly positive, high-resolution computed tomography chest showed evidence of interstitial lung disease (ILD) with mediastinal lymphadenopathy and histopathology of skin biopsy were suggestive of systemic sclerosis. Correlating the occupational history, clinical features, haematological investigations and histological findings, a diagnosis of Erasmus syndrome was safely made.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48905557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pulmonary actinomycosis presenting as a pleural tumour 肺部放线菌病表现为胸膜肿瘤
Pub Date : 2020-01-01 DOI: 10.4103/jacp.jacp_27_18
Neeraj Keyal, Raju Shrestha, Niru Nepal, Manish Nakarmi
Pulmonary actinomycosis is a rare gram positive higher prokaryotic bacterial infection. We hereby present a case of 78-year old male presented with non-specific symptoms like cough, shortness of breath (SOB) and chest pain mimicking as pulmonary tuberculosis, fungal infection and lung cancer but was diagnosed to have pulmonary actinomycosis. From this, we want to emphasize that pulmonary actinomycosis should be evaluated in all patients that are not responding to anti-tubercular and lung cancer treatment.
肺放线菌病是一种罕见的革兰氏阳性高等原核细菌感染。我们在此报告一例78岁男性病例,表现为咳嗽、呼吸急促(SOB)和胸痛等非特异性症状,类似肺结核、真菌感染和肺癌癌症,但被诊断为肺部放线菌病。由此,我们想强调的是,所有对抗结核和癌症治疗无效的患者都应该评估肺部放线菌病。
{"title":"Pulmonary actinomycosis presenting as a pleural tumour","authors":"Neeraj Keyal, Raju Shrestha, Niru Nepal, Manish Nakarmi","doi":"10.4103/jacp.jacp_27_18","DOIUrl":"https://doi.org/10.4103/jacp.jacp_27_18","url":null,"abstract":"Pulmonary actinomycosis is a rare gram positive higher prokaryotic bacterial infection. We hereby present a case of 78-year old male presented with non-specific symptoms like cough, shortness of breath (SOB) and chest pain mimicking as pulmonary tuberculosis, fungal infection and lung cancer but was diagnosed to have pulmonary actinomycosis. From this, we want to emphasize that pulmonary actinomycosis should be evaluated in all patients that are not responding to anti-tubercular and lung cancer treatment.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42191996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disseminated Multidrug-Resistant Tuberculosis in a Young Patient: A Rare Case Report 一例年轻患者的播散性耐多药结核病:罕见病例报告
Pub Date : 2020-01-01 DOI: 10.4103/jacp.jacp_21_19
Ritu Dadra, N. Kajal, B. Malhotra, P. Pandiyaraj, L. Kaur, G. Kaur
Drug resistance is a persistent threat to tuberculosis (TB) control program worldwide. Patients infected with multiple drug-resistant strains are less likely to become cured. Management of resistant cases is complex and presents therapeutic limitations. Patients with multidrug-resistant strains are more prone to treatment failure and progress to more chronic forms of the disease and death. According to the Global Tuberculosis Report 2018, about 3.5% of newly diagnosed patients had multidrug-resistant tuberculosis (MDR-TB) and 18% of previously treated TB cases were estimated to have MDR-TB. This case presented a rare occurrence of disseminated MDR-TB in a diabetic patient. A case of a 14-year-old female, who was an old-treated case of abdominal TB, presented with 5 months of history of fever, breathlessness, and pain in the abdomen with diabetes mellitus, in whom disseminated MDR-TB was documented with fine-needle aspiration cytology of abdominal lymph nodes and bronchoalveolar lavage fluid that showed drug-resistant TB. So this case emphasizes the importance of screening all extrapulmonary TB patients for drug resistance especially if the patient also has associated comorbid conditions.
耐药性是世界范围内结核病控制计划的一个持续威胁。感染多种耐药菌株的患者治愈的可能性较小。耐药病例的管理是复杂的,并且存在治疗局限性。耐多药菌株患者更容易出现治疗失败,并发展为更慢性的疾病和死亡。根据《2018年全球结核病报告》,约3.5%的新诊断患者患有耐多药结核病(MDR-TB),18%的既往治疗结核病病例估计患有MDR-TB。该病例为糖尿病患者罕见的播散性耐多药结核病。一例14岁女性,是一例腹部结核的老患者,有5个月的糖尿病发烧、呼吸困难和腹部疼痛史,腹部淋巴结和支气管肺泡灌洗液的细针抽吸细胞学检查显示有耐药性结核。因此,本病例强调了对所有肺外结核患者进行耐药性筛查的重要性,尤其是如果患者也有相关的合并症。
{"title":"Disseminated Multidrug-Resistant Tuberculosis in a Young Patient: A Rare Case Report","authors":"Ritu Dadra, N. Kajal, B. Malhotra, P. Pandiyaraj, L. Kaur, G. Kaur","doi":"10.4103/jacp.jacp_21_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_21_19","url":null,"abstract":"Drug resistance is a persistent threat to tuberculosis (TB) control program worldwide. Patients infected with multiple drug-resistant strains are less likely to become cured. Management of resistant cases is complex and presents therapeutic limitations. Patients with multidrug-resistant strains are more prone to treatment failure and progress to more chronic forms of the disease and death. According to the Global Tuberculosis Report 2018, about 3.5% of newly diagnosed patients had multidrug-resistant tuberculosis (MDR-TB) and 18% of previously treated TB cases were estimated to have MDR-TB. This case presented a rare occurrence of disseminated MDR-TB in a diabetic patient. A case of a 14-year-old female, who was an old-treated case of abdominal TB, presented with 5 months of history of fever, breathlessness, and pain in the abdomen with diabetes mellitus, in whom disseminated MDR-TB was documented with fine-needle aspiration cytology of abdominal lymph nodes and bronchoalveolar lavage fluid that showed drug-resistant TB. So this case emphasizes the importance of screening all extrapulmonary TB patients for drug resistance especially if the patient also has associated comorbid conditions.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46955172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Journal of Association of Chest Physicians
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1